GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mira Pharmaceuticals Inc (STU:K6S) » Definitions » Cash Flow from Others

Mira Pharmaceuticals (STU:K6S) Cash Flow from Others : €-0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Mira Pharmaceuticals Cash Flow from Others?

Mira Pharmaceuticals's cash flow from others for the three months ended in Dec. 2024 was €-0.00 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Dec. 2024 was €-0.00 Mil.


Mira Pharmaceuticals Cash Flow from Others Historical Data

The historical data trend for Mira Pharmaceuticals's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mira Pharmaceuticals Cash Flow from Others Chart

Mira Pharmaceuticals Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Cash Flow from Others
0.02 0.01 5.08 -

Mira Pharmaceuticals Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cash Flow from Others Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.43 - - - -

Mira Pharmaceuticals Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.00 Mil.

Mira Pharmaceuticals Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of Mira Pharmaceuticals's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.


Mira Pharmaceuticals Business Description

Traded in Other Exchanges
Address
1200 Brickell Avenue, Suite 1950 No. 1183, Miami, FL, USA, 33133
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Mira Pharmaceuticals Headlines

No Headlines